|
ASX - By Stock
|
ATH |
Re:
Ann: Unmarketable Parcel Sale Facility
|
|
andymonroe
|
82 |
16K |
4 |
11/04/26 |
| 11/04/26 |
ASX - By Stock
|
82
|
16K
|
4
|
|
|
ASX - By Stock
|
ATH Biotech |
Re:
Stock price - ATH/ATHE
|
|
andymonroe
|
3.4K |
1.0M |
2 |
09/04/26 |
| 09/04/26 |
ASX - By Stock
|
3.4K
|
1.0M
|
2
|
|
|
General
|
ATH |
Re:
The everything and anything thread
|
|
andymonroe
|
466 |
84K |
13 |
07/04/26 |
| 07/04/26 |
General
|
466
|
84K
|
13
|
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Alterity Receives Positive FDA Feedback From Type C Meeting
|
|
andymonroe
|
43 |
10K |
5 |
03/04/26 |
| 03/04/26 |
ASX - By Stock
|
43
|
10K
|
5
|
|
|
General
|
ATH |
Re:
The everything and anything thread
|
|
andymonroe
|
466 |
84K |
2 |
28/03/26 |
| 28/03/26 |
General
|
466
|
84K
|
2
|
|
|
ASX - By Stock
|
ATH |
ATH 434 Patent Application
|
|
andymonroe
|
2 |
859 |
11 |
28/03/26 |
| 28/03/26 |
ASX - By Stock
|
2
|
859
|
11
|
|
|
ASX - By Stock
|
ATH |
Hair metal dysregulation in PD: Gut-Brain axis involvement
|
|
andymonroe
|
0 |
207 |
2 |
19/02/26 |
| 19/02/26 |
ASX - By Stock
|
0
|
207
|
2
|
|
|
ASX - By Stock
|
ATH Biotech |
Re:
Stock price - ATH/ATHE
|
|
andymonroe
|
3.4K |
1.0M |
9 |
16/02/26 |
| 16/02/26 |
ASX - By Stock
|
3.4K
|
1.0M
|
9
|
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Initial Director's Interest Notice - Stamler
|
|
andymonroe
|
3 |
1.0K |
6 |
26/11/25 |
| 26/11/25 |
ASX - By Stock
|
3
|
1.0K
|
6
|
|
|
ASX - By Stock
|
ATH Biotech |
Re:
Stock price - ATH/ATHE
|
|
andymonroe
|
3.4K |
1.0M |
4 |
25/11/25 |
| 25/11/25 |
ASX - By Stock
|
3.4K
|
1.0M
|
4
|
|
|
ASX - By Stock
|
ATH Biotech |
Re:
Stock price - ATH/ATHE
|
|
andymonroe
|
3.4K |
1.0M |
3 |
03/11/25 |
| 03/11/25 |
ASX - By Stock
|
3.4K
|
1.0M
|
3
|
|
|
ASX - By Stock
|
ATH Biotech |
Re:
Stock price - ATH/ATHE
|
|
andymonroe
|
3.4K |
1.0M |
0 |
02/11/25 |
| 02/11/25 |
ASX - By Stock
|
3.4K
|
1.0M
|
0
|
|
|
ASX - By Stock
|
ATH Biotech |
Re:
Stock price - ATH/ATHE
|
|
andymonroe
|
3.4K |
1.0M |
4 |
01/11/25 |
| 01/11/25 |
ASX - By Stock
|
3.4K
|
1.0M
|
4
|
|
|
ASX - By Stock
|
ATH Biotech |
Re:
Stock price - ATH/ATHE
|
|
andymonroe
|
3.4K |
1.0M |
8 |
29/10/25 |
| 29/10/25 |
ASX - By Stock
|
3.4K
|
1.0M
|
8
|
|
|
ASX - By Stock
|
ATH Biotech |
Re:
Stock price - ATH/ATHE
|
|
andymonroe
|
3.4K |
1.0M |
2 |
29/10/25 |
| 29/10/25 |
ASX - By Stock
|
3.4K
|
1.0M
|
2
|
|
|
ASX - By Stock
|
ATH Biotech |
Re:
Stock price - ATH/ATHE
|
|
andymonroe
|
3.4K |
1.0M |
7 |
24/10/25 |
| 24/10/25 |
ASX - By Stock
|
3.4K
|
1.0M
|
7
|
|
|
ASX - By Stock
|
ATH Biotech |
Re:
Stock price - ATH/ATHE
|
|
andymonroe
|
3.4K |
1.0M |
3 |
20/10/25 |
| 20/10/25 |
ASX - By Stock
|
3.4K
|
1.0M
|
3
|
|
|
ASX - By Stock
|
ATH Biotech |
Re:
Stock price - ATH/ATHE
|
|
andymonroe
|
3.4K |
1.0M |
6 |
19/10/25 |
| 19/10/25 |
ASX - By Stock
|
3.4K
|
1.0M
|
6
|
|
|
ASX - By Stock
|
ATH Biotech |
Re:
Stock price - ATH/ATHE
|
|
andymonroe
|
3.4K |
1.0M |
8 |
18/10/25 |
| 18/10/25 |
ASX - By Stock
|
3.4K
|
1.0M
|
8
|
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Change in substantial holding
|
|
andymonroe
|
38 |
7.8K |
9 |
15/10/25 |
| 15/10/25 |
ASX - By Stock
|
38
|
7.8K
|
9
|
|
|
ASX - By Stock
|
ATH |
Re:
Huge vol in NY
|
|
andymonroe
|
17 |
3.9K |
16 |
10/10/25 |
| 10/10/25 |
ASX - By Stock
|
17
|
3.9K
|
16
|
|
|
ASX - By Stock
|
ATH Biotech |
Re:
News, articles and interviews
|
|
andymonroe
|
440 |
145K |
4 |
03/10/25 |
| 03/10/25 |
ASX - By Stock
|
440
|
145K
|
4
|
|
|
ASX - By Stock
|
ATH Biotech |
Re:
Lateral thinking
|
|
andymonroe
|
61 |
6.3K |
1 |
02/10/25 |
| 02/10/25 |
ASX - By Stock
|
61
|
6.3K
|
1
|
|
|
ASX - By Stock
|
ATH Biotech |
Re:
Lateral thinking
|
|
andymonroe
|
61 |
6.3K |
4 |
02/10/25 |
| 02/10/25 |
ASX - By Stock
|
61
|
6.3K
|
4
|
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Alterity Reports New Commercial Assessment for ATH434 in MSA
|
|
andymonroe
|
152 |
16K |
9 |
29/09/25 |
| 29/09/25 |
ASX - By Stock
|
152
|
16K
|
9
|
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Alterity Raises A$20.0 million in Strategic Placement
|
|
andymonroe
|
123 |
21K |
14 |
08/09/25 |
| 08/09/25 |
ASX - By Stock
|
123
|
21K
|
14
|
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Alterity Raises A$20.0 million in Strategic Placement
|
|
andymonroe
|
123 |
21K |
13 |
08/09/25 |
| 08/09/25 |
ASX - By Stock
|
123
|
21K
|
13
|
|
|
ASX - By Stock
|
ATH Biotech |
Re:
Stock price - ATH/ATHE
|
|
andymonroe
|
3.4K |
1.0M |
7 |
11/08/25 |
| 11/08/25 |
ASX - By Stock
|
3.4K
|
1.0M
|
7
|
|
|
ASX - By Stock
|
ATH Biotech |
Re:
Stock price - ATH/ATHE
|
|
andymonroe
|
3.4K |
1.0M |
4 |
04/08/25 |
| 04/08/25 |
ASX - By Stock
|
3.4K
|
1.0M
|
4
|
|
|
ASX - By Stock
|
ATH Biotech |
Re:
News, articles and interviews
|
|
andymonroe
|
440 |
145K |
5 |
04/08/25 |
| 04/08/25 |
ASX - By Stock
|
440
|
145K
|
5
|
|
|
ASX - By Stock
|
ATH Biotech |
Re:
Stock price - ATH/ATHE
|
|
andymonroe
|
3.4K |
1.0M |
3 |
18/07/25 |
| 18/07/25 |
ASX - By Stock
|
3.4K
|
1.0M
|
3
|
|
|
ASX - By Stock
|
ATH Biotech |
Re:
Stock price - ATH/ATHE
|
|
andymonroe
|
3.4K |
1.0M |
2 |
04/06/25 |
| 04/06/25 |
ASX - By Stock
|
3.4K
|
1.0M
|
2
|
|
|
ASX - By Stock
|
ATH Biotech |
Re:
Stock price - ATH/ATHE
|
|
andymonroe
|
3.4K |
1.0M |
2 |
04/06/25 |
| 04/06/25 |
ASX - By Stock
|
3.4K
|
1.0M
|
2
|
|
|
ASX - By Stock
|
ATH Biotech |
Re:
Stock price - ATH/ATHE
|
|
andymonroe
|
3.4K |
1.0M |
2 |
30/05/25 |
| 30/05/25 |
ASX - By Stock
|
3.4K
|
1.0M
|
2
|
|
|
ASX - By Stock
|
ATH Biotech |
Re:
Stock price - ATH/ATHE
|
|
andymonroe
|
3.4K |
1.0M |
4 |
19/05/25 |
| 19/05/25 |
ASX - By Stock
|
3.4K
|
1.0M
|
4
|
|
|
ASX - By Stock
|
ATH |
Re:
Short activity
|
|
andymonroe
|
44 |
15K |
3 |
13/05/25 |
| 13/05/25 |
ASX - By Stock
|
44
|
15K
|
3
|
|
|
ASX - By Stock
|
ATH Biotech |
Re:
Stock price - ATH/ATHE
|
|
andymonroe
|
3.4K |
1.0M |
10 |
07/05/25 |
| 07/05/25 |
ASX - By Stock
|
3.4K
|
1.0M
|
10
|
|
|
ASX - By Stock
|
ATH Biotech |
Re:
Stock price - ATH/ATHE
|
|
andymonroe
|
3.4K |
1.0M |
0 |
21/03/25 |
| 21/03/25 |
ASX - By Stock
|
3.4K
|
1.0M
|
0
|
|
|
ASX - By Stock
|
ATH Biotech |
Re:
Stock price - ATH/ATHE
|
|
andymonroe
|
3.4K |
1.0M |
4 |
15/03/25 |
| 15/03/25 |
ASX - By Stock
|
3.4K
|
1.0M
|
4
|
|
|
ASX - By Stock
|
ATH Biotech |
Re:
Stock price - ATH/ATHE
|
|
andymonroe
|
3.4K |
1.0M |
5 |
15/03/25 |
| 15/03/25 |
ASX - By Stock
|
3.4K
|
1.0M
|
5
|
|
|
ASX - By Stock
|
ATH Biotech |
Re:
Stock price - ATH/ATHE
|
|
andymonroe
|
3.4K |
1.0M |
3 |
14/03/25 |
| 14/03/25 |
ASX - By Stock
|
3.4K
|
1.0M
|
3
|
|
|
ASX - By Stock
|
ATH Biotech |
Re:
Stock price - ATH/ATHE
|
|
andymonroe
|
3.4K |
1.0M |
4 |
27/02/25 |
| 27/02/25 |
ASX - By Stock
|
3.4K
|
1.0M
|
4
|
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy
|
|
andymonroe
|
507 |
173K |
7 |
25/02/25 |
| 25/02/25 |
ASX - By Stock
|
507
|
173K
|
7
|
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy
|
|
andymonroe
|
507 |
173K |
5 |
25/02/25 |
| 25/02/25 |
ASX - By Stock
|
507
|
173K
|
5
|
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy
|
|
andymonroe
|
507 |
173K |
12 |
25/02/25 |
| 25/02/25 |
ASX - By Stock
|
507
|
173K
|
12
|
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy
|
|
andymonroe
|
507 |
173K |
4 |
24/02/25 |
| 24/02/25 |
ASX - By Stock
|
507
|
173K
|
4
|
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy
|
|
andymonroe
|
507 |
173K |
6 |
24/02/25 |
| 24/02/25 |
ASX - By Stock
|
507
|
173K
|
6
|
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy
|
|
andymonroe
|
507 |
173K |
13 |
24/02/25 |
| 24/02/25 |
ASX - By Stock
|
507
|
173K
|
13
|
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Change in substantial holding
|
|
andymonroe
|
63 |
25K |
2 |
07/02/25 |
| 07/02/25 |
ASX - By Stock
|
63
|
25K
|
2
|
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Change in substantial holding
|
|
andymonroe
|
63 |
25K |
1 |
07/02/25 |
| 07/02/25 |
ASX - By Stock
|
63
|
25K
|
1
|
|